{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:33:12Z","timestamp":1792459992040,"version":"4.5.0"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01ES09601\/EPA-R826886"],"award-info":[{"award-number":["P01ES09601\/EPA-R826886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01ES09883"],"award-info":[{"award-number":["R01ES09883"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL67406"],"award-info":[{"award-number":["R01HL67406"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30ES07033"],"award-info":[{"award-number":["P30ES07033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P42ES04696"],"award-info":[{"award-number":["P42ES04696"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U50OH07544"],"award-info":[{"award-number":["U50OH07544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.cbi.2016.05.036","type":"journal-article","created":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T18:06:15Z","timestamp":1464372375000},"page":"51-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":183,"special_numbering":"PB","title":["Paraoxonases-1, -2 and -3: What are their functions?"],"prefix":"10.1016","volume":"259","author":[{"given":"Clement E.","family":"Furlong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Marsillach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail P.","family":"Jarvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio G.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2016.05.036_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1042\/bj0530110","article-title":"Serum esterases. I. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination","volume":"53","author":"Aldridge","year":"1953","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2016.05.036_bib2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1006\/geno.1996.0225","article-title":"The human serum paraoxonase\/arylesterase gene (PON1) is one member of a multigene family","volume":"33","author":"Primo-Parmo","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.cbi.2016.05.036_bib3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0009-2797(99)00075-7","article-title":"Recommended nomenclature system for the paraoxonases","volume":"119\u2013120","author":"La Du","year":"1999","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2016.05.036_bib4","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1074\/jbc.M107440200","article-title":"Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism","volume":"277","author":"Deakin","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.freeradbiomed.2008.03.023","article-title":"Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues","volume":"45","author":"Marsillach","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2016.05.036_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1042\/bj0530117","article-title":"Serum esterases. II. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera","volume":"53","author":"Aldridge","year":"1953","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2016.05.036_bib7","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1073\/pnas.92.16.7187","article-title":"Reconsideration of the catalytic center and mechanism of mammalian paraoxonase\/arylesterase","volume":"92","author":"Sorenson","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cbi.2016.05.036_bib8","doi-asserted-by":"crossref","first-page":"12780","DOI":"10.1073\/pnas.0805865105","article-title":"Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning","volume":"105","author":"Stevens","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cbi.2016.05.036_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/02772248809357310","article-title":"The human paraoxonase-polymorphism and specificity","volume":"18","author":"Geldmacher-von Mallinckrodt","year":"1988","journal-title":"Toxicol. Environ. Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib10","series-title":"Paraoxonase (PON1) in Health and Disease: Basic and Clinical Aspects","first-page":"53","article-title":"PON1 polymorphisms","author":"Brophy","year":"2002"},{"key":"10.1016\/j.cbi.2016.05.036_bib11","first-page":"295","article-title":"Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin","volume":"36","author":"Ortigoza-Ferado","year":"1984","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cbi.2016.05.036_bib12","first-page":"35","article-title":"Simulated dermal contamination with capillary samples and field cholinesterase biomonitoring","volume":"51","author":"Yuknavage","year":"1997","journal-title":"J.\u00a0Toxicol. Environ. Health"},{"key":"10.1016\/j.cbi.2016.05.036_bib13","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1021\/jf970635q","article-title":"Diminution of chlorpyrifos and chlorpyrifos oxon in tomatoes and green geans grown in greenhouses","volume":"46","author":"Martinez Vidal","year":"1998","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.chemosphere.2014.03.064","article-title":"Development of a passive air sampler to measure airborne organophosphorus pesticides and oxygen analogs in an agricultural community","volume":"111","author":"Armstrong","year":"2014","journal-title":"Chemosphere"},{"key":"10.1016\/j.cbi.2016.05.036_bib15","doi-asserted-by":"crossref","first-page":"10133","DOI":"10.1021\/bi00106a009","article-title":"Purification of rabbit and human serum paraoxonase","volume":"30","author":"Furlong","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2016.05.036_bib16","doi-asserted-by":"crossref","first-page":"10141","DOI":"10.1021\/bi00106a010","article-title":"Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence","volume":"30","author":"Hassett","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2016.05.036_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ng0193-73","article-title":"The molecular basis of the human serum paraoxonase activity polymorphism","volume":"3","author":"Humbert","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cbi.2016.05.036_bib18","first-page":"598","article-title":"Molecular basis for the polymorphic forms of human serum paraoxonase\/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes","volume":"52","author":"Adkins","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cbi.2016.05.036_bib19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00008571-200012000-00002","article-title":"Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds","volume":"10","author":"Li","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.cbi.2016.05.036_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/ng1196-334","article-title":"The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin","volume":"14","author":"Davies","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cbi.2016.05.036_bib21","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/320600","article-title":"Effects of 5\u2019 regulatory-region polymorphisms on paraoxonase-gene (PON1) expression","volume":"68","author":"Brophy","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cbi.2016.05.036_bib22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0021-9150(99)00379-2","article-title":"A\u00a0polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression","volume":"150","author":"Suehiro","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cbi.2016.05.036_bib23","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s001250100610","article-title":"The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients","volume":"44","author":"Leviev","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2016.05.036_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2013.01.036","article-title":"A\u00a0functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis","volume":"228","author":"Liu","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cbi.2016.05.036_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuron.2015.11.025","article-title":"Cytoplasmic Rbfox1 regulates the expression of synaptic and autism-related genes","volume":"89","author":"Lee","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.cbi.2016.05.036_bib26","series-title":"The Paraoxonases: Their Role in Disease, Development and Xenobiotic Metabolism","first-page":"267","article-title":"The functional consequences of polymorphisms in the human PON1 gene","author":"Furlong","year":"2008"},{"key":"10.1016\/j.cbi.2016.05.036_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00008571-200305000-00009","article-title":"Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status","volume":"13","author":"Jarvik","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.cbi.2016.05.036_bib28","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1194\/jlr.P049247","article-title":"Rare coding variation in paraoxonase-1 is associated with ischemic stroke in the NHLBI exome sequencing project","volume":"55","author":"Kim","year":"2014","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.cbi.2016.05.036_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1139\/y56-023","article-title":"The Role of A-esterase in the acute toxicity of paraoxon, TEEP and parathion","volume":"34","author":"Main","year":"1956","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.cbi.2016.05.036_bib30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0041-008X(90)90263-T","article-title":"Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats","volume":"103","author":"Costa","year":"1990","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2016.05.036_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/15287399309531798","article-title":"Serum paraoxonase status: a major factor in determining resistance to organophosphates","volume":"40","author":"Li","year":"1993","journal-title":"J.\u00a0Toxicol. Environ. Health"},{"key":"10.1016\/j.cbi.2016.05.036_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0378-4274(95)80006-Y","article-title":"Paraoxonase protects against chlorpyrifos toxicity in mice","volume":"76","author":"Li","year":"1995","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2016.05.036_bib33","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"Shih","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2016.05.036_bib34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0003-2697(89)90424-7","article-title":"Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase\/arylesterase","volume":"180","author":"Furlong","year":"1989","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cbi.2016.05.036_bib35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.fpc.0000167327.08034.d2","article-title":"Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism","volume":"15","author":"Cole","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.cbi.2016.05.036_bib36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/toxsci\/kfr157","article-title":"Repeated developmental exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1)-modulated effects on cerebellar gene expression","volume":"123","author":"Cole","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2016.05.036_bib37","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nsmb767","article-title":"Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes","volume":"11","author":"Harel","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cbi.2016.05.036_bib38","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00204-014-1204-z","article-title":"Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in\u00a0vivo and to detoxify structurally different nerve agents in\u00a0vitro","volume":"88","author":"Worek","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2016.05.036_bib39","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.chembiol.2012.01.017","article-title":"Evolved stereoselective hydrolases for broad-spectrum G-type nerve agent detoxification","volume":"19","author":"Goldsmith","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.cbi.2016.05.036_bib40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","article-title":"Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein","volume":"286","author":"Mackness","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cbi.2016.05.036_bib41","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00008571-199912000-00009","article-title":"Determination of paraoxonase (PON1) status requires more than genotyping","volume":"9","author":"Richter","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.cbi.2016.05.036_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/CIRCGENETICS.108.811638","article-title":"Determination of paraoxonase 1 status without the use of toxic organophosphate substrates","volume":"1","author":"Richter","year":"2008","journal-title":"Circ. Cardiovasc Genet."},{"key":"10.1016\/j.cbi.2016.05.036_bib43","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1161\/01.ATV.20.11.2441","article-title":"Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype","volume":"20","author":"Jarvik","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cbi.2016.05.036_bib44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.ATV.21.4.473","article-title":"Paraoxonase and atherosclerosis","volume":"21","author":"Durrington","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cbi.2016.05.036_bib45","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease","volume":"121","author":"Besler","year":"2011","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.cbi.2016.05.036_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.atherosclerosis.2006.07.024","article-title":"Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection","volume":"194","author":"Parra","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cbi.2016.05.036_bib47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2005.12.018","article-title":"Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases","volume":"45","author":"Ferre","year":"2006","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cbi.2016.05.036_bib48","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.clinbiochem.2007.01.020","article-title":"Serum paraoxonase-1 in chronic alcoholics: relationship with liver disease","volume":"40","author":"Marsillach","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cbi.2016.05.036_bib49","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.clinbiochem.2013.08.020","article-title":"Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome","volume":"46","author":"Ferre","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cbi.2016.05.036_bib50","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1194\/jlr.P028977","article-title":"Paraoxonase-1 status in patients with hereditary hemochromatosis","volume":"54","author":"Martinelli","year":"2013","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.cbi.2016.05.036_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.femsle.2005.09.023","article-title":"Human and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorum-sensing","volume":"253","author":"Ozer","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.cbi.2016.05.036_bib52","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1172\/JCI35147","article-title":"Drosophila are protected from Pseudomonas aeruginosa lethality by transgenic expression of paraoxonase-1","volume":"118","author":"Stoltz","year":"2008","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.cbi.2016.05.036_bib53","doi-asserted-by":"crossref","first-page":"30425","DOI":"10.1074\/jbc.C200267200","article-title":"Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease","volume":"277","author":"Jakubowski","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib54","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cbi.2016.05.036_bib55","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.STR.0000128412.59768.6e","article-title":"Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis","volume":"35","author":"Undas","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.cbi.2016.05.036_bib56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.febslet.2011.12.018","article-title":"Effect of N-homocysteinylation on physicochemical and cytotoxic properties of amyloid beta-peptide","volume":"586","author":"Khodadadi","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cbi.2016.05.036_bib57","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1074\/jbc.275.6.3957","article-title":"Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation","volume":"275","author":"Jakubowski","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib58","doi-asserted-by":"crossref","first-page":"22485","DOI":"10.1074\/jbc.M603656200","article-title":"Protective mechanisms against homocysteine toxicity: the role of bleomycin hydrolase","volume":"281","author":"Zimny","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib59","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0090-9556(24)15082-9","article-title":"Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters","volume":"28","author":"Billecke","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2016.05.036_bib60","series-title":"Paraoxonase (PON1) in Health and Disease: Basic and Clinical Aspects","first-page":"1","article-title":"Historical considerations","author":"La Du","year":"2002"},{"key":"10.1016\/j.cbi.2016.05.036_bib61","doi-asserted-by":"crossref","first-page":"e110054","DOI":"10.1371\/journal.pone.0110054","article-title":"Human valacyclovir hydrolase\/biphenyl hydrolase-like protein is a highly efficient homocysteine thiolactonase","volume":"9","author":"Marsillach","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2016.05.036_bib62","doi-asserted-by":"crossref","first-page":"12926","DOI":"10.1074\/jbc.270.21.12926","article-title":"Cloning and expression analysis of a novel human serine hydrolase with sequence similarity to prokaryotic enzymes involved in the degradation of aromatic compounds","volume":"270","author":"Puente","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib63","doi-asserted-by":"crossref","first-page":"25348","DOI":"10.1074\/jbc.M302055200","article-title":"Identification of a human valacyclovirase: biphenyl hydrolase-like protein as valacyclovir hydrolase","volume":"278","author":"Kim","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib64","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0378-1119(98)00193-0","article-title":"Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence","volume":"213","author":"Mochizuki","year":"1998","journal-title":"Gene"},{"key":"10.1016\/j.cbi.2016.05.036_bib65","doi-asserted-by":"crossref","first-page":"44444","DOI":"10.1074\/jbc.M105660200","article-title":"Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein","volume":"276","author":"Ng","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib66","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.taap.2011.02.014","article-title":"Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role?","volume":"256","author":"Giordano","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2016.05.036_bib67","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/01.ATV.0000059385.95664.4D","article-title":"Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress","volume":"23","author":"Rosenblat","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cbi.2016.05.036_bib68","doi-asserted-by":"crossref","first-page":"G1252","DOI":"10.1152\/ajpgi.00369.2007","article-title":"Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of humans and rats","volume":"293","author":"Levy","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.cbi.2016.05.036_bib69","doi-asserted-by":"crossref","first-page":"L852","DOI":"10.1152\/ajplung.00370.2006","article-title":"Paraoxonase-2 deficiency enhances Pseudomonas aeruginosa quorum sensing in murine tracheal epithelia","volume":"292","author":"Stoltz","year":"2007","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.cbi.2016.05.036_bib70","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/ars.2010.3430","article-title":"Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis","volume":"14","author":"Devarajan","year":"2011","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.cbi.2016.05.036_bib71","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/CIRCULATIONAHA.106.681700","article-title":"Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation","volume":"115","author":"Horke","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2016.05.036_bib72","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00210-003-0833-1","article-title":"Pharmacogenetics of paraoxonases: a brief review","volume":"369","author":"Draganov","year":"2004","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.cbi.2016.05.036_bib73","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1194\/jlr.M400511-JLR200","article-title":"Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities","volume":"46","author":"Draganov","year":"2005","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.cbi.2016.05.036_bib74","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1600-065X.1983.tb01093.x","article-title":"Steroids as immunosuppressants in pregnancy","volume":"75","author":"Stites","year":"1983","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cbi.2016.05.036_bib75","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1128\/IAI.01606-07","article-title":"Dominant role of paraoxonases in inactivation of the Pseudomonas aeruginosa quorum-sensing signal N-(3-oxododecanoyl)-L-homoserine lactone","volume":"76","author":"Teiber","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cbi.2016.05.036_bib76","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1042\/BJ20091414","article-title":"Paraoxonase 2 is down-regulated by the Pseudomonas aeruginosa quorumsensing signal N-(3-oxododecanoyl)-L-homoserine lactone and attenuates oxidative stress induced by pyocyanin","volume":"426","author":"Horke","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2016.05.036_bib77","doi-asserted-by":"crossref","first-page":"35564","DOI":"10.1074\/jbc.M109.051706","article-title":"A\u00a0common mutation in paraoxonase-2 results in impaired lactonase activity","volume":"284","author":"Stoltz","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib78","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1086\/345312","article-title":"Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women\u2019s Ischemia Syndrome Evaluation (WISE) study","volume":"72","author":"Chen","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cbi.2016.05.036_bib79","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.molbrainres.2003.10.018","article-title":"Possible association between Cys311Ser polymorphism of paraoxonase 2 gene and late-onset Alzheimer\u2019s disease in Chinese","volume":"120","author":"Shi","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.cbi.2016.05.036_bib80","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2796.2005.01554.x","article-title":"The paraoxonase-2-310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus","volume":"258","author":"Mackness","year":"2005","journal-title":"J.\u00a0Intern Med."},{"key":"10.1016\/j.cbi.2016.05.036_bib81","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ymgme.2009.05.008","article-title":"Paraoxonase2 C311S polymorphism and low levels of HDL contribute to a higher mortality risk after acute myocardial infarction in elderly patients","volume":"98","author":"Marchegiani","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cbi.2016.05.036_bib82","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1007\/s11033-011-1367-0","article-title":"Association between paraoxonase 2 Ser311Cys polymorphism and ischemic stroke risk: a meta-analysis involving 5,008 subjects","volume":"39","author":"Li","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.cbi.2016.05.036_bib83","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.biocel.2009.02.013","article-title":"Comparative expression analysis reveals differences in the regulation of intestinal paraoxonase family members","volume":"41","author":"Precourt","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cbi.2016.05.036_bib84","doi-asserted-by":"crossref","first-page":"29491","DOI":"10.1074\/jbc.M605379200","article-title":"Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2","volume":"281","author":"Ng","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib85","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ymgme.2006.07.004","article-title":"Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice","volume":"89","author":"Ng","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cbi.2016.05.036_bib86","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1194\/jlr.M800550-JLR200","article-title":"Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1","volume":"50","author":"Rosenblat","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.cbi.2016.05.036_bib87","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2009.07.057","article-title":"Paraoxonase 2 (PON2) decreases high glucose-induced macrophage triglycerides (TG) accumulation, via inhibition of NADPH-oxidase and DGAT1 activity: studies in PON2-deficient mice","volume":"208","author":"Meilin","year":"2010","journal-title":"Atherosclerosis"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.cbi.2016.05.036_bib88","doi-asserted-by":"crossref","first-page":"S453","DOI":"10.3233\/JAD-2010-100321","article-title":"Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury","volume":"20","author":"Higgins","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.cbi.2016.05.036_bib89","doi-asserted-by":"crossref","first-page":"24398","DOI":"10.1074\/jbc.M110.118604","article-title":"One enzyme, two functions: PON2 prevents mitochondrial superoxide formation and apoptosis independent from its lactonase activity","volume":"285","author":"Altenhofer","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib90","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1042\/BJ20101891","article-title":"Impaired hepatic insulin signalling in PON2-deficient mice: a novel role for the PON2\/apoE axis on the macrophage inflammatory response","volume":"436","author":"Bourquard","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2016.05.036_bib91","first-page":"352857","article-title":"Paraoxonases-2 and -3 are important defense enzymes against pseudomonas aeruginosa virulence factors due to their anti-oxidative and anti-inflammatory properties","volume":"2012","author":"Schweikert","year":"2012","journal-title":"J.\u00a0Lipids"},{"key":"10.1016\/j.cbi.2016.05.036_bib92","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/iub.347","article-title":"Human tissue distribution of paraoxonases 1 and 2 mRNA","volume":"62","author":"Mackness","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.cbi.2016.05.036_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2016.04.001","article-title":"Developmental expression of paraoxonase 2","author":"Garrick","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2016.05.036_bib94","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.freeradbiomed.2013.01.019","article-title":"Gender differences in brain susceptibility to oxidative stress are mediated by levels of paraoxonase-2 expression","volume":"58","author":"Giordano","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2016.05.036_bib95","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s11064-013-1085-1","article-title":"Modulation of paraoxonase 2 (PON2) in mouse brain by the polyphenol quercetin: a mechanism of neuroprotection?","volume":"38","author":"Costa","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cbi.2016.05.036_bib96","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.freeradbiomed.2005.03.016","article-title":"Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2","volume":"39","author":"Shamir","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2016.05.036_bib97","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1038\/cddis.2010.91","article-title":"Beyond reduction of atherosclerosis: PON2 provides apoptosis resistance and stabilizes tumor cells","volume":"2","author":"Witte","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2016.05.036_bib98","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/BJ20080775","article-title":"Protective effect of paraoxonase-2 against endoplasmic reticulum stress-induced apoptosis is lost upon disturbance of calcium homoeostasis","volume":"416","author":"Horke","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2016.05.036_bib99","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.freeradbiomed.2004.09.003","article-title":"Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages","volume":"37","author":"Shiner","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2016.05.036_bib100","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.bbagen.2009.11.013","article-title":"Mitochondrial mechanisms of estrogen neuroprotection","volume":"1800","author":"Simpkins","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2016.05.036_bib101","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbagen.2009.10.002","article-title":"Actions of estrogens on glial cells: implications for neuroprotection","volume":"1800","author":"Arevalo","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2016.05.036_bib102","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/j.1460-9568.2010.07516.x","article-title":"Role of astroglia in the neuroplastic and neuroprotective actions of estradiol","volume":"32","author":"Azcoitia","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.cbi.2016.05.036_bib103","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jsbmb.2012.01.012","article-title":"Estrogen and the regulation of mitochondrial structure and function in the brain","volume":"131","author":"Arnold","year":"2012","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cbi.2016.05.036_bib104","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neuroscience.2011.08.045","article-title":"The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson\u2019s disease","volume":"198","author":"Surmeier","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.cbi.2016.05.036_bib105","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am. J. Epidemiol."},{"issue":"Suppl 1","key":"10.1016\/j.cbi.2016.05.036_bib106","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","article-title":"Epidemiology and etiology of Parkinson\u2019s disease: a review of the evidence","volume":"26","author":"Wirdefeldt","year":"2011","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.cbi.2016.05.036_bib107","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.freeradbiomed.2012.05.015","article-title":"Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase","volume":"53","author":"Yang","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2016.05.036_bib108","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cbi.2016.05.036_bib109","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/HYPERTENSIONAHA.110.150839","article-title":"Female adult mouse cardiomyocytes are protected against oxidative stress","volume":"55","author":"Wang","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.cbi.2016.05.036_bib110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.envres.2006.10.001","article-title":"Implications of gender differences for human health risk assessment and toxicology","volume":"104","author":"Vahter","year":"2007","journal-title":"Environ. Res."},{"key":"10.1016\/j.cbi.2016.05.036_bib111","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0149-7634(00)00027-0","article-title":"The effects of hormones on sex differences in infection: from genes to behavior","volume":"24","author":"Klein","year":"2000","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.cbi.2016.05.036_bib112","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/aje\/kwm115","article-title":"The female advantage in cardiovascular disease: do vascular beds contribute equally?","volume":"166","author":"Kardys","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.cbi.2016.05.036_bib113","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bcp.2004.08.027","article-title":"Modulation of paraoxonase (PON1) activity","volume":"69","author":"Costa","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2016.05.036_bib114","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bcp.2010.11.008","article-title":"Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on","volume":"81","author":"Costa","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2016.05.036_bib115","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2174\/138955709788681591","article-title":"Pharmacological and lifestyle factors modulating serum paraoxonase-1 activity","volume":"9","author":"Camps","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib116","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.atherosclerosis.2009.11.044","article-title":"Increased macrophage cholesterol biosynthesis and decreased cellular paraoxonase 2 (PON2) expression in Delta6-desaturase knockout (6-DS KO) mice: beneficial effects of arachidonic acid","volume":"210","author":"Rosenblat","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cbi.2016.05.036_bib117","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1515\/BC.2007.145","article-title":"Macrophage paraoxonase 2 (PON2) expression is upregulated by unesterified cholesterol through activation of the phosphatidylinositol 3-kinase (PI3K) pathway","volume":"388","author":"Shiner","year":"2007","journal-title":"Biol. Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib118","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/ptr.3318","article-title":"Glabridin, a phytoestrogen from licorice root, up-regulates manganese superoxide dismutase, catalase and paraoxonase 2 under glucose stress","volume":"25","author":"Yehuda","year":"2011","journal-title":"Phytother. Res."},{"key":"10.1016\/j.cbi.2016.05.036_bib119","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.ATV.0000104011.88939.06","article-title":"Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy","volume":"24","author":"Rosenblat","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cbi.2016.05.036_bib120","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1161\/ATVBAHA.108.166041","article-title":"Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism","volume":"28","author":"Fuhrman","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cbi.2016.05.036_bib121","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/cvr\/cvp184","article-title":"Urokinase activates macrophage PON2 gene transcription via the PI3K\/ROS\/MEK\/SREBP-2 signalling cascade mediated by the PDGFR-beta","volume":"84","author":"Fuhrman","year":"2009","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.cbi.2016.05.036_bib122","doi-asserted-by":"crossref","first-page":"421","DOI":"10.5483\/BMBRep.2009.42.7.421","article-title":"Transcriptional activation of an anti-oxidant mouse Pon2 gene by dexamethasone","volume":"42","author":"Lim","year":"2009","journal-title":"BMB Rep."},{"key":"10.1016\/j.cbi.2016.05.036_bib123","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2007.01.007","article-title":"Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR gamma and AP-1 pathway activation","volume":"195","author":"Shiner","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cbi.2016.05.036_bib124","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.3390\/ijms10094168","article-title":"Effect of quercetin on paraoxonase 2 levels in RAW264.7 macrophages and in human monocytes\u2013role of quercetin metabolism","volume":"10","author":"Boesch-Saadatmandi","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2016.05.036_bib125","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.nut.2012.04.011","article-title":"Yerba mate (Ilex paraguariensis) enhances the gene modulation and activity of paraoxonase-2: in\u00a0vitro and in\u00a0vivo studies","volume":"28","author":"Fernandes","year":"2012","journal-title":"Nutrition"},{"key":"10.1016\/j.cbi.2016.05.036_bib126","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/01.ATV.21.4.542","article-title":"Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids","volume":"21","author":"Reddy","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cbi.2016.05.036_bib127","doi-asserted-by":"crossref","first-page":"33435","DOI":"10.1074\/jbc.M004543200","article-title":"Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation","volume":"275","author":"Draganov","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib128","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.freeradbiomed.2007.05.003","article-title":"Paraoxonases are associated with intestinal inflammatory diseases and intracellularly localized to the endoplasmic reticulum","volume":"43","author":"Rothem","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2016.05.036_bib129","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/cdd.2012.35","article-title":"PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death","volume":"19","author":"Schweikert","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cbi.2016.05.036_bib130","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1096\/fj.14-260570","article-title":"PON3 knockout mice are susceptible to obesity, gallstone formation, and atherosclerosis","volume":"29","author":"Shih","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.cbi.2016.05.036_bib131","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pep.2005.07.021","article-title":"Cloning, purification, and refolding of human paraoxonase-3 expressed in Escherichia coli and its characterization","volume":"46","author":"Lu","year":"2006","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.cbi.2016.05.036_bib132","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mrfmmm.2003.11.007","article-title":"Identification of paraoxonase 3 gene (PON3) missense mutations in a population of southern Italy","volume":"546","author":"Campo","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/j.cbi.2016.05.036_bib133","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1136\/gut.2006.107953","article-title":"Paraoxonase 1, 2 and 3 DNA variants and susceptibility to childhood inflammatory bowel disease","volume":"55","author":"Sanchez","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cbi.2016.05.036_bib134","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/hmg\/ddi428","article-title":"Polymorphisms in the PON gene cluster are associated with Alzheimer disease","volume":"15","author":"Erlich","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cbi.2016.05.036_bib135","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1194\/jlr.D014134","article-title":"Measurement of serum PON-3 concentration: method evaluation, reference values, and influence of genotypes in a population-based study","volume":"52","author":"Aragones","year":"2011","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.cbi.2016.05.036_bib136","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1194\/jlr.P018457","article-title":"Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidation","volume":"53","author":"Aragones","year":"2012","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.cbi.2016.05.036_bib137","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.atherosclerosis.2011.11.021","article-title":"Serum paraoxonase-3 concentration is associated with insulin sensitivity in peripheral artery disease and with inflammation in coronary artery disease","volume":"220","author":"Rull","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cbi.2016.05.036_bib138","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.clinbiochem.2011.08.003","article-title":"Serum paraoxonase-3 concentration is associated with the severity of hepatic impairment in patients with chronic liver disease","volume":"44","author":"Garcia-Heredia","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cbi.2016.05.036_bib139","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/pr5011586","article-title":"Paraoxonase-3 is depleted from the high-density lipoproteins of autoimmune disease patients with subclinical atherosclerosis","volume":"14","author":"Marsillach","year":"2015","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.cbi.2016.05.036_bib140","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/01.RES.0000264499.48737.69","article-title":"Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice","volume":"100","author":"Shih","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2016.05.036_bib141","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/ATVBAHA.106.134189","article-title":"Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"27","author":"Carey","year":"2007","journal-title":"Atheroscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cbi.2016.05.036_bib142","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2004.09.035","article-title":"The paraoxonase gene family and atherosclerosis","volume":"38","author":"Ng","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2016.05.036_bib143","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-60761-350-3_8","article-title":"Temporal and tissue-specific patterns of Pon3 expression in mouse: in situ hybridization analysis","volume":"660","author":"Shih","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cbi.2016.05.036_bib144","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.molmed.2004.10.002","article-title":"The role of pyocyanin in Pseudomonas aeruginosa infection","volume":"10","author":"Lau","year":"2004","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.cbi.2016.05.036_bib145","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1128\/IAI.66.12.5777-5784.1998","article-title":"Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells","volume":"66","author":"Denning","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cbi.2016.05.036_bib146","first-page":"355","article-title":"Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent","volume":"26","author":"Tougou","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2016.05.036_bib147","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1021\/jm990436t","article-title":"Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism","volume":"43","author":"Biggadike","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.cbi.2016.05.036_bib148","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0006-2952(03)00401-5","article-title":"Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3","volume":"66","author":"Teiber","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2016.05.036_bib149","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1021\/bi047440d","article-title":"Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase","volume":"44","author":"Khersonsky","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2016.05.036_bib150","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1124\/dmd.114.057372","article-title":"Hepatic, intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in\u00a0vitro-in\u00a0vivo extrapolation of clearance of prodrugs","volume":"42","author":"Nishimuta","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2016.05.036_bib151","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1016\/j.bmcl.2014.07.016","article-title":"Novel Roflumilast analogs as soft PDE4 inhibitors","volume":"24","author":"Boland","year":"2014","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2016.05.036_bib152","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nm.2281","article-title":"Paraoxonase-1 is a major determinant of clopidogrel efficacy","volume":"17","author":"Bouman","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2016.05.036_bib153","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/nm.2386","article-title":"Paraoxonase-1 and clopidogrel efficacy","volume":"17","author":"Camps","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2016.05.036_bib154","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1021\/tx2004085","article-title":"Cytochromes P450 catalyze both steps of the major pathway of clopidogrel bioactivation, whereas paraoxonase catalyzes the formation of a minor thiol metabolite isomer","volume":"25","author":"Dansette","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2016.05.036_bib155","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1021\/acs.chemrestox.5b00133","article-title":"Bioactivation of clopidogrel and prasugrel: factors determining the stereochemistry of the thiol metabolite double bond","volume":"28","author":"Dansette","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2016.05.036_bib156","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/geno.1995.1261","article-title":"The genetic mapping and gene structure of mouse paraoxonase\/arylesterase","volume":"30","author":"Sorenson","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.cbi.2016.05.036_bib157","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1006\/geno.1996.0401","article-title":"Structural organization of the human PON1 gene","volume":"35","author":"Clendenning","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.cbi.2016.05.036_bib158","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.neuro.2010.09.005","article-title":"Same sex, no sex, and unaware sex in neurotoxicology","volume":"32","author":"Weiss","year":"2011","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cbi.2016.05.036_bib159","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1126\/science.327.5973.1571","article-title":"Biomedical research. Of mice and women: the bias in animal models","volume":"327","author":"Wald","year":"2010","journal-title":"Science"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279716302150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279716302150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:45:43Z","timestamp":1757857543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279716302150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":159,"alternative-id":["S0009279716302150"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2016.05.036","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraoxonases-1, -2 and -3: What are their functions?","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2016.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}